• Santaris Pharma A/S, of Hoersholm, Denmark, said the European Patent Office issued minutes of the oral proceedings specifying the board of appeal's decision to maintain EP 1015469, the "Wengel" patent, with claims to amino- and thio-LNA nucleotides and oligonucleotides.